Sepsis resident survival guide
Sepsis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Sepsis resident survival guide On the Web |
American Roentgen Ray Society Images of Sepsis resident survival guide |
Risk calculators and risk factors for Sepsis resident survival guide |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]
Definition
- Sepsis = Infection + SIRS
- The presence of systemic inflammatory syndrome (SIRS) is due to many factors. The presence of infection increases the chances of sepsis and increase the SIRS criteria .
- The endothelial dysfunction is the main trigger transforming the localized infection into systemic organ dysfunction
- There is no definitive biomarkers have been associated with the endothelial dysfunction of sepsis.
SIRS is diagnosed by 2 or more of the following:
- Tachycardia > 90 bpm
- Tachypnea > 20 breaths per minute or on blood gas, a PaCO2 < 32 mm Hg
- Temperature < 36 (96.8 °F) or > 38 °C (100.4 °F)
- White blood cell count < 4000 cells/mm³ ( < 4 x 109cells/L ) or > 12000 cells/mm³ ( > 12 x 109 cells/L) or > 10% bandemia ( immature WBCs ).
Sepsis is diagnosed by at least 1 of the following signs of organ failure: [HOME]
- Hypoxemia (arterial oxygen tension [PaO2] < 72 mm Hg at fraction of inspired oxygen [FiO2] 0.21; overt pulmonary disease not the direct cause of hypoxemia)
- Oiguria (urine output < 30 mL or 0.5 mL/kg for at least 1 h)
- Mental status alteration
- Elevated plasma lactate level > 4 mmol/L
Severe sepsis
- Sepsis + organ dysfunction
- Organ damage can present as decreased urine output, acute kidney injury, and elevated liver function tests.
Septic shock
- Severe sepsis + persistent hypotension after adequate fluid challenge.
Multiple organ dysfunction syndrome (MODS) is the presence of altered organ function in a acutely ill patient whom homeostasis cannot be maintained without intervention.
Diagnostic Criteria For Sepsis (Documented/Suspected Infection Plus Inflammatory variablesPlus One of The Organ Dysfunction)
- General variables
- Fever > 38.3°C
- Hypothermia ( core temperature < 36°C )
- Heart rate > 90/min–1 or > 2 SD above the normal value for age
- Tachypnea
- Altered mental status
- Edema
- Positive fluid balance ( > 20 mL/kg over 24 hr)
- Hyperglycemia ( plasma glucose > 140 mg/dL or 7.7 mmol/L ) in the absence of diabetes
- Inflammatory variables
- Leukocytosis ( WBC count > 12,000 µL–1 )
- Leukopenia ( WBC count < 4000 µL–1 )
- Immature WBCs forms are > 10% with normal count
- Plasma C-reactive protein > 2 SD above the normal value
- Plasma procalcitonin > 2 SD above the normal value
- Hemodynamic variables
- Arterial hypotension after 30 ml/kg fluid bolus ( SBP < 90 mm Hg, MAP < 70 mm Hg, or an SBP decrease > 40 mm Hg in adults or < 2 SD below normal for age )
- Organ dysfunction variables
- Arterial hypoxemia ( Pao2/Fio2 < 300 )
- Acute oliguria ( urine output < 0.5 mL/kg/hr for at least 2 hrs despite adequate fluid resuscitation )
- Creatinine increase > 0.5 mg/dL or 44.2 µmol/L
- Coagulation abnormalities ( INR > 1.5 or aPTT > 60 Sec )
- Ileus ( absent bowel sounds )
- Thrombocytopenia ( platelet count < 100,000 µL–1 )
- Hyperbilirubinemia ( plasma total bilirubin > 4 mg/dL or 70 µmol/L )
- Tissue perfusion variables
- Hyperlactatemia > 1 mmol/L
- Decreased capillary refill or mottling
- Evidence of acute lung injury (ALI):[1]
- Oxygenation abnormality with a PaO2/FiO2 ratio < 300
- Chest Xray with bilateral opacities compatible with pulmonary edema
- PA < 18 mm Hg or no clinical evidence of left atrial hypertension if PaO2 is not available
- Acute respiratory distress syndrome (ARDS) is a more severe form of ALI and is defined similarly but a characteristic PaO2/FiO2 ratio is < 200
Causes
Life Threatening Causes
Common Causes
- Community acquired pneumonia: 48% develop severe sepsis.[7]
- Diabetes and renal disease may explain the higher rates of infection related septic shock.
- Immunosuppression
Prognosis
- Advanced age > 65 year old: a strong correlation exists between the incidence of septic shock in patients older than 50 years.
- Organ dysfunction is more related to bad prognosis than meeting SIRS criteria. A study found that just meeting SIRS criteria without evidence of organ dysfunction did not predict increased mortality. This concludes the importance of identification of organs dysfunction over the presence of SIRS criteria.[8]
Management
Goals during the first six hours of fluid resuscitation, as suggested by the Surviving Sepsis Campaign guidelines, include the following:[9]
- CVP 8-12 mmHg
- SCVo2 (superior vena cava) 70% or SVo2 65%
- MAP ≥ 65 mmHg
- Urine output ≥ 0.5 mL/kg/hour
Sepsis screening Patient identification | |||||||||||||||||||||||||||||
History of infection | |||||||||||||||||||||||||||||
Yes, history of infection | No History | ||||||||||||||||||||||||||||
Yes,Clinical symptoms | No clinical symptoms | ||||||||||||||||||||||||||||
Activate Sepsis Protocol Blood culture 2X, then early antibiotics within 1 hr Check lactate elevation, evidence of organ dysfunction | No lactate No evidence of organ dysfunction Normal tissue perfusion | ||||||||||||||||||||||||||||
Tissue hypoperfusion | |||||||||||||||||||||||||||||
Yes, Tissue hypoperfusion | No tissue hypoperfusion | ||||||||||||||||||||||||||||
SBO ≤ 90mm Hg MAP ≤ 65 mm Hg Lactate ≥ 4mmol/L | |||||||||||||||||||||||||||||
Protocol A and B | Protocol B | ||||||||||||||||||||||||||||
PROTOCOL A Sepsis-induced Hypoperfusion Clinical picture plus < 65mm Hg Lactate > 4mmol/L | |||||||||||||||||||||||||||||||||||
Supplemental O2 (Targeted by O2) Fluid resuscitation at least crystalloid bolus or colloid equivalent 20ml/kg | |||||||||||||||||||||||||||||||||||
CVP measurement | |||||||||||||||||||||||||||||||||||
CVP < 8mm Hg | |||||||||||||||||||||||||||||||||||
Crystalloid bolus or colloid equivalent till CVP > 8 mm Hg | CVP > 8mm Hg | ||||||||||||||||||||||||||||||||||
MAP | |||||||||||||||||||||||||||||||||||
MAP < 65 mmHg | |||||||||||||||||||||||||||||||||||
Vasopressors ( 1st line Norepinephrine 0.05 mcg/kg/min ) ( 2nd line Dopamine / Vasopressin ) (3rd-4th line Phenylephrine ) till MAP > 65 mmHg | MAP > 65 mmHg | ||||||||||||||||||||||||||||||||||
SeVO2 | |||||||||||||||||||||||||||||||||||
SeVO2 < 70% | SeVO2 > 70% | ||||||||||||||||||||||||||||||||||
Transfuse PRBCs, if HCT ≤ 30 Dobutamine if HCT > 30 | |||||||||||||||||||||||||||||||||||
Goals achieved | Goals achieved | ||||||||||||||||||||||||||||||||||
Resuscitation completed Reevaluate | Vasopressors still required Stress Dose Steroids | ||||||||||||||||||||||||||||||||||
PROTOCOL B Sepsis shock with NO tissue hypoperfusion Normal Perfusion | |||||||||||||||||||||||||||||||||
Assess requirement for Mechanical ventilation (Targeted by O2) | Infection source identification Empirical antibiotics after 2 blood cultures | Plasma glucose level | |||||||||||||||||||||||||||||||
Mechanical ventilation required | No mechanical ventilation required | < 180 mg/dl maintain < 150 mg/dl | > 180 mg/dl | ||||||||||||||||||||||||||||||
Semi Recumbent position Lung-protective ventilation for ALI/ARDS Maintain intermittent positive pressure (IPPP) < 30 cm H2o | Start insulin to keep glucose < 150 | ||||||||||||||||||||||||||||||||
Do's
Do within 3 Hours
- Measure lactate level.
- Obtain at least 2 sets of blood cultures and cultures of other relevant sites, provided it does not cause a delay exceeding 45 minutes in starting antimicrobial therapy.
- Administer broad spectrum antibiotics at least 1 drug with activity against all likely pathogens ( bacterial, fungal, or viral )
- Administer adequate fluid challenge (40-60 mL/kg) crystalloid for hypotension or lactate 4 mmol/L.
- Maintian CVP 8-12 cm H2o in non-intubated patients, and CVP 12-15 cm H2o for intubated patients.
Do within 6 Hours
- Apply vasopressors in hypotension refractory to initial fluid resuscitation.
- Maintain a mean arterial pressure (MAP) ≥ 65 mm Hg.
- In persistent arterial hypotension despite volume resuscitation or initial lactate 4 mmol/L ( 36 mg/dL ): check CVPand ScvO2.
- Re-measure lactate if initial lactate was elevated.
- Initiating broad-spectrum coverage until the specific organism is cultured and antibiotic sensitivities are determined is important.
Don'ts
- Routine use of hemodynamic drugs to raise cardiac output to supranormal levels is not recommended.
- Increasing the cardiac index in order to enhance the oxygen delivery has no improvement on outcome but it has worsened morbidity and mortality.
- Administration of bicarbonate in order to correct the acidosis may worsen the intracellular acidosis. Correction of acidemia with sodium bicarbonate has not been proved to improve hemodynamics in a critically ill patient with increased blood lactate levels.
- Immunosuppressive agents that could suppress the overwhelming inflammatory mediators responsible for MODs, as high-dose corticosteroids, have not shown any benefit in humans. However the encouraging data from animal studies.
- Unfractionated heparin in patients with sepsis did not have any beneficial effect on length of hospital stay, MODs, and mortality compared to placebo.[10]
References
- ↑ Bernard, GR.; Artigas, A.; Brigham, KL.; Carlet, J.; Falke, K.; Hudson, L.; Lamy, M.; Legall, JR.; Morris, A. (1994). "The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination". Am J Respir Crit Care Med. 149 (3 Pt 1): 818–24. doi:10.1164/ajrccm.149.3.7509706. PMID 7509706. Unknown parameter
|month=
ignored (help) - ↑ Jones, GR.; Lowes, JA. (1996). "The systemic inflammatory response syndrome as a predictor of bacteraemia and outcome from sepsis". QJM. 89 (7): 515–22. PMID 8759492. Unknown parameter
|month=
ignored (help) - ↑ Brun-Buisson, C.; Doyon, F.; Carlet, J.; Dellamonica, P.; Gouin, F.; Lepoutre, A.; Mercier, JC.; Offenstadt, G.; Régnier, B. (1995). "Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis". JAMA. 274 (12): 968–74. PMID 7674528. Unknown parameter
|month=
ignored (help) - ↑ Sands, KE.; Bates, DW.; Lanken, PN.; Graman, PS.; Hibberd, PL.; Kahn, KL.; Parsonnet, J.; Panzer, R.; Orav, EJ. (1997). "Epidemiology of sepsis syndrome in 8 academic medical centers". JAMA. 278 (3): 234–40. PMID 9218672. Unknown parameter
|month=
ignored (help) - ↑ Kumar, A.; Roberts, D.; Wood, KE.; Light, B.; Parrillo, JE.; Sharma, S.; Suppes, R.; Feinstein, D.; Zanotti, S. (2006). "Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock". Crit Care Med. 34 (6): 1589–96. doi:10.1097/01.CCM.0000217961.75225.E9. PMID 16625125. Unknown parameter
|month=
ignored (help) - ↑ Bernard, GR.; Vincent, JL.; Laterre, PF.; LaRosa, SP.; Dhainaut, JF.; Lopez-Rodriguez, A.; Steingrub, JS.; Garber, GE.; Helterbrand, JD. (2001). "Efficacy and safety of recombinant human activated protein C for severe sepsis". N Engl J Med. 344 (10): 699–709. doi:10.1056/NEJM200103083441001. PMID 11236773. Unknown parameter
|month=
ignored (help) - ↑ Dremsizov, T.; Clermont, G.; Kellum, JA.; Kalassian, KG.; Fine, MJ.; Angus, DC. (2006). "Severe sepsis in community-acquired pneumonia: when does it happen, and do systemic inflammatory response syndrome criteria help predict course?". Chest. 129 (4): 968–78. doi:10.1378/chest.129.4.968. PMID 16608946. Unknown parameter
|month=
ignored (help) - ↑ Shapiro, N.; Howell, MD.; Bates, DW.; Angus, DC.; Ngo, L.; Talmor, D. (2006). "The association of sepsis syndrome and organ dysfunction with mortality in emergency department patients with suspected infection". Ann Emerg Med. 48 (5): 583–90, 590.e1. doi:10.1016/j.annemergmed.2006.07.007. PMID 17052559. Unknown parameter
|month=
ignored (help) - ↑ Dellinger, RP.; Levy, MM.; Rhodes, A.; Annane, D.; Gerlach, H.; Opal, SM.; Sevransky, JE.; Sprung, CL.; Douglas, IS. (2013). "Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012". Intensive Care Med. 39 (2): 165–228. doi:10.1007/s00134-012-2769-8. PMID 23361625. Unknown parameter
|month=
ignored (help) - ↑ Jaimes, F.; De La Rosa, G.; Morales, C.; Fortich, F.; Arango, C.; Aguirre, D.; Muñoz, A. (2009). "Unfractioned heparin for treatment of sepsis: A randomized clinical trial (The HETRASE Study)". Crit Care Med. 37 (4): 1185–96. doi:10.1097/CCM.0b013e31819c06bc. PMID 19242322. Unknown parameter
|month=
ignored (help)